XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning balance (in shares) at Dec. 31, 2022       153,830 312        
Beginning balance at Dec. 31, 2022 $ (329.3)     $ 0.2 $ 0.0 $ 1,912.6 $ (2,422.6) $ 178.0 $ 2.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 47.4           47.3   0.1
Equity-based compensation, including amounts capitalized 74.5         74.5      
Stock option exercises (in shares)       132          
Stock option exercises 3.2         3.2      
Repurchases of Class A common stock (in shares)       (1,553)          
Repurchases of Class A common stock (113.9)           (113.9)    
Impact of derivatives, net (39.5)             (39.5)  
Change in foreign currency translation adjustment 2.1             2.1  
Vesting of restricted stock units and other (in shares)       1,705 5        
Vesting of restricted stock units and other 0.0         0.2 (0.1) 0.1 (0.2)
Ending balance (in shares) at Mar. 31, 2023       154,114 307        
Ending balance at Mar. 31, 2023 (355.5)     $ 0.2 $ 0.0 1,990.5 (2,489.3) 140.7 $ 2.4
Beginning balance (in shares) at Dec. 31, 2023   142,051 259 142,051 259 [1]        
Beginning balance at Dec. 31, 2023 62.2     $ 0.1 $ 0.0 2,271.6 (2,320.7) 111.2  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 401.5           401.5    
Equity-based compensation, including amounts capitalized 72.3         72.3      
Stock option exercises (in shares)       80          
Stock option exercises 2.1         2.1      
Repurchases of Class A common stock (in shares) [2]       (1,245)          
Repurchases of Class A common stock [2] (147.1)           (147.1)    
Impact of derivatives, net 19.8             19.8  
Change in foreign currency translation adjustment 3.8             3.8  
Vesting of restricted stock units and other (in shares)       1,543 259 [1]        
Vesting of restricted stock units and other 0.2         (0.1) 0.1 0.2  
Ending balance (in shares) at Mar. 31, 2024   142,429 0 [3] 142,429 0 [1]        
Ending balance at Mar. 31, 2024 $ 414.8     $ 0.1 $ 0.0 $ 2,345.9 $ (2,066.2) $ 135.0  
[1] Substantially all Class B shares were no longer outstanding as of March 31, 2024. See Note 1 for further discussion.
[2] Includes a 1% excise tax on shares repurchased, net of the fair market value of new share issuances, of $0.5 million.
[3] Substantially all Class B shares were no longer outstanding as of March 31, 2024.